Articles matching the ‘Cardiovascular risk’ Category

October 22nd, 2010

Podcast 105: NSAIDs revisited

In the face of scheduling problems we’ve had to postpone this week’s interview and use, instead, one from early this summer. It’s on NSAIDs, and if you missed it, it’s worth a listen. If you didn’t miss it, then join us again next week, but give a listen to the news round-up before you head […]


October 1st, 2010

Podcast 103: eGFR and cardiovascular risk assessment

Welcome back. We take a look this week at a study from Iceland that looks at whether estimated glomerular filtration rates have a role in estimating cardiovascular risk. Our interview is with Cambridge University’s Dr. Emanuele Di Angelantonio. Your comments are welcome, both here and to my email address: jelia@jwatch.org. Interview-related links: BMJ study (free) BMJ meta-analysis (free) […]


July 1st, 2010

Podcast 94: What does a new meta-analysis tell us about statins and primary prevention?

A meta-analysis of 11 studies encompassing more than 60,000 subjects finds that statins don’t lower all-cause mortality in people without cardiovascular disease. One editorialist calls the study, just published in the Archives of Internal Medicine, “the cleanest and most complete meta-analysis of pharmacological lipid lowering for primary prevention.” One of the study’s principal authors, Kausik K. […]


June 11th, 2010

Podcast 91: What risks do NSAIDs hold for healthy people? They’re not trivial.

We talk with a Danish researcher, Emil Fosbøl, whose team estimated the risks of cardiovascular events caused by NSAID use in healthy people. Your feedback is always welcomed and encouraged. Please drop me a note (jelia@jwatch.org) or call in a comment to 1-617-440-4374. I’m eager to act on your suggestions. The interview-related link: First Watch coverage of the […]


February 5th, 2010

Podcast 73: How best to monitor patients on androgen-deprivation therapy for cardiovascular risks?

A panel of the American Heart Association, the American Cancer Society, and the American Urological Association issued a statement on androgen-deprivation therapy and cardiovascular risk. We’ve got an interview with the chair of the writing committee, Dr. Glenn Levine. Interview-related links: Physician’s First Watch coverage of the statement Link to the statement, as published in Circulation News-related links: […]


Clinical Conversations

About the Podcast

Comments, suggestions, and story ideas welcome. Learn more about Clinical Conversations.

Follow us:
Follow on Apple Podcasts

Listen on Youtube

Follow on Spotify